Candel Therapeutics (CADL) Current Leases (2022 - 2025)
Candel Therapeutics (CADL) posted Current Leases of $445000.0 for Q4 2025, up 1.83% sequentially from $437000.0 in Q3 2025, and down 21.38% YoY from $566000.0 in Q4 2024.
Candel Therapeutics (CADL) Current Leases (2022 - 2025) Analysis & Trends
Candel Therapeutics has reported Current Leases for 4 years, with the latest figure at $445000.0 in Q4 2025.
- Quarterly Current Leases fell 21.38% year-over-year to $445000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $445000.0 (down 21.38% YoY) and the FY2025 annual result came in at $445000.0, down 21.38% from the prior year.
- Current Leases climbed to $445000.0 in Q4 2025 per CADL's latest filing, from $437000.0 in the prior quarter.
- Over five years, Current Leases peaked at $594000.0 in Q2 2025 and troughed at $429000.0 in Q1 2022.
- A 4-year average of $500062.5 and a median of $494000.0 in 2023 frame the typical range for Current Leases.
- The sharpest annual moves came in 2023 and 2025: Current Leases increased 10.96% in 2023, then declined 21.38% in 2025.
- Over 4 years, Current Leases stood at $464000.0 in 2022, then increased by 10.56% to $513000.0 in 2023, then gained by 10.33% to $566000.0 in 2024, then dropped by 21.38% to $445000.0 in 2025.
- According to Business Quant data, Current Leases over the past three periods registered $445000.0, $437000.0, and $594000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Candel Therapeutics | 643.41 Mn | 643.41 Mn | - | 445,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 445,000.00 |
| Sep 30, 2025 | 437,000.00 |
| Jun 30, 2025 | 594,000.00 |
| Mar 31, 2025 | 580,000.00 |
| Dec 31, 2024 | 566,000.00 |
| Sep 30, 2024 | 552,000.00 |
| Jun 30, 2024 | 539,000.00 |
| Mar 31, 2024 | 526,000.00 |
| Dec 31, 2023 | 513,000.00 |
| Sep 30, 2023 | 500,000.00 |
| Jun 30, 2023 | 488,000.00 |
| Mar 31, 2023 | 476,000.00 |
| Dec 31, 2022 | 464,000.00 |
| Sep 30, 2022 | 452,000.00 |
| Jun 30, 2022 | 440,000.00 |
| Mar 31, 2022 | 429,000.00 |